| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| François Giuliano, Wayne J G Hellstro. The pharmacological treatment of premature ejaculation. BJU international. vol 102. issue 6. 2008-10-29. PMID:18485043. |
selective serotonin reuptake inhibitor (ssri) antidepressants (paroxetine, fluoxetine and sertraline) and the tricyclic antidepressant clomipramine increase ejaculatory control and delay ejaculation in men with pe, suggesting that pharmacological intervention might be useful for pe. |
2008-10-29 |
2023-08-12 |
Not clear |
| Thomas Kümler, Daniel Hedlund, Robert Hast, Hans C Hasselbalc. [Aquagenic pruritus from polycythaemia vera--treatment with paroxetine, a selective serotonin reuptake inhibitor]. Ugeskrift for laeger. vol 170. issue 38. 2008-09-29. PMID:18808757. |
[aquagenic pruritus from polycythaemia vera--treatment with paroxetine, a selective serotonin reuptake inhibitor]. |
2008-09-29 |
2023-08-12 |
Not clear |
| Kiyomi Matsuzawa-Yanagida, Minoru Narita, Mayumi Nakajima, Naoko Kuzumaki, Keiichi Niikura, Hiroyuki Nozaki, Tomoe Takagi, Eiko Tamai, Nana Hareyama, Mioko Terada, Mitsuaki Yamazaki, Tsutomu Suzuk. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 8. 2008-09-02. PMID:17957217. |
under these conditions, repeated administration of antidepressants, including the tricyclic antidepressant (tca) imipramine, the serotonin noradrenaline reuptake inhibitor (snri) milnacipran, and the selective serotonin reuptake inhibitor (ssri) paroxetine, significantly prevented the anxiety-related behaviors induced by chronic neuropathic pain. |
2008-09-02 |
2023-08-12 |
mouse |
| Ivar Aursnes, Marianne Klemp Gjertse. Common adverse events associated with an SSRI: meta-analysis of early paroxetine data. Pharmacoepidemiology and drug safety. vol 17. issue 7. 2008-08-20. PMID:18383561. |
we wanted to determine to what extent adverse drug effects associated with a selective serotonin reuptake inhibitor (ssri) were known but not assessed before application for registration of paroxetine. |
2008-08-20 |
2023-08-12 |
Not clear |
| S Landy, J McGinnis, D Curlin, S C Laizur. Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache. vol 39. issue 1. 2008-08-01. PMID:15613191. |
this finding is compared to other studies with the serotonin selective reuptake inhibitors, fluoxetine, fluvoxamine, and paroxetine. |
2008-08-01 |
2023-08-12 |
human |
| Masaki Kato, Masataka Wakeno, Gaku Okugawa, Tsuyoshi Fukuda, Yoshiteru Takekita, Yuka Hosoi, Junichi Azuma, Toshihiko Kinoshita, Alessandro Serrett. Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 4. 2008-07-22. PMID:18325652. |
the aim of the present study is to test a possible effect of the c825t polymorphism on the antidepressant response and intolerance to selective serotonin reuptake inhibitors (ssris) in 146 japanese samples with major depression treated with paroxetine or fluvoxamine for 6 weeks. |
2008-07-22 |
2023-08-12 |
human |
| C P Bots, A van Nieuw Amerongen, H S Bran. [Painful palate and xerostomia after using paroxetine]. Nederlands tijdschrift voor tandheelkunde. vol 115. issue 5. 2008-07-08. PMID:18543695. |
this article presents the case of a 58-year-old woman with diabetes mellitus type 2 who, for one and a half years, had been using paroxetine, a specific serotonin re-uptake inhibitor, to reduce a depression. |
2008-07-08 |
2023-08-12 |
Not clear |
| C P Bots, A van Nieuw Amerongen, H S Bran. [Painful palate and xerostomia after using paroxetine]. Nederlands tijdschrift voor tandheelkunde. vol 115. issue 5. 2008-07-08. PMID:18543695. |
this case report suggests a causal relationship between, on the one hand, paroxetine and other serotonin re-uptake inhibitors and, on the other, atypical oral pain as well as hyposalivation. |
2008-07-08 |
2023-08-12 |
Not clear |
| Peter Vestergaard, Lars Rejnmark, Leif Mosekild. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcified tissue international. vol 82. issue 2. 2008-06-26. PMID:18219438. |
among the selective serotonin reuptake inhibitors, citalopram, fluoxetine, and sertraline were associated with a dose-dependent increase in fracture risk, while the increase was borderline statistically insignificant for paroxetine. |
2008-06-26 |
2023-08-12 |
Not clear |
| Marian K Bakker, Pieternel Kölling, Paul B van den Berg, Hermien E K de Walle, Lolkje T W de Jong van den Ber. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British journal of clinical pharmacology. vol 65. issue 4. 2008-06-11. PMID:17953715. |
* recently, the use of selective serotonin reuptake inhibitors (ssris), particularly paroxetine, in pregnancy has been associated with an increased risk on specific birth defects or other adverse pregnancy outcomes. |
2008-06-11 |
2023-08-12 |
Not clear |
| Terje Vasskog, Trude Anderssen, Stig Pedersen-Bjergaard, Roland Kallenborn, Einar Jense. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. Journal of chromatography. A. vol 1185. issue 2. 2008-05-30. PMID:18280486. |
a method for the determination of five selective serotonin reuptake inhibitors (citalopram, sertraline, fluoxetine, fluvoxamine and paroxetine) and four of their metabolites (desmethylcitalopram, didesmethylcitalopram, norfluoxetine and desmethylsertraline) in seawater and sewage influents and effluents, has been developed and validated. |
2008-05-30 |
2023-08-12 |
Not clear |
| Francis E Lotrich, Bruce G Pollock, Margaret Kirshner, Robert F Ferrell, Charles F Reynolds Ii. Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. Journal of psychiatry & neuroscience : JPN. vol 33. issue 2. 2008-05-30. PMID:18330458. |
serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. |
2008-05-30 |
2023-08-12 |
Not clear |
| Muneyuki Sakata, Yuichi Kimura, Mika Naganawa, Masatomo Ishikawa, Keiichi Oda, Kenji Ishii, Kenji Hashimoto, Kunihiro Chihara, Kiichi Ishiwat. Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification. Annals of nuclear medicine. vol 22. issue 2. 2008-05-27. PMID:18311540. |
tissue time-activity curves of 288 regions of interest in the brain from 32 [(11)c]sa4503-pet scans of 16 healthy subjects prior to and following administration of a selective serotonin reuptake inhibitor (fluvoxamine or paroxetine) were applied to two algorithms of quantitative analysis; binding potential (bp) was derived from compartmental analysis based on nonlinear estimation, and total distribution volume (tdv) was derived from logan plot analysis. |
2008-05-27 |
2023-08-12 |
human |
| David Baldwin, John Hutchison, Kirsteen Donaldson, Bob Shaw, Andrew Smither. Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670. Journal of psychopharmacology (Oxford, England). vol 22. issue 1. 2008-05-22. PMID:17715211. |
previously depressed male or female patients in symptomatic remission receiving stable doses of fluoxetine or paroxetine but experiencing treatment-emergent sexual dysfunction were randomised to double-blind treatment with placebo or vml-670 (a 5-ht(1a) and 5-ht(1d) agonist). |
2008-05-22 |
2023-08-12 |
Not clear |
| Francis E Lotrich, Robert R Bies, Gwenn S Smith, Bruce G Polloc. Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies. Journal of psychopharmacology (Oxford, England). vol 20. issue 4 Suppl. 2008-05-15. PMID:16785268. |
we also present preliminary evidence that the concentration-response relationship for paroxetine is influenced by genotypic differences at the serotonin transporter promoter. |
2008-05-15 |
2023-08-12 |
Not clear |
| Bankole A Johnson, Martin A Javors, John D Roache, Chamindi Seneviratne, Susan E Bergeson, Nassima Ait-Daoud, Michael A Dawes, Jennie Z M. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 1. 2008-05-02. PMID:17950969. |
for l-carriers, the mean of bmax for paroxetine binding, but not vmax for serotonin (5-ht) uptake, was lower than that for ss subjects (p<0.05). |
2008-05-02 |
2023-08-12 |
human |
| Bankole A Johnson, Martin A Javors, John D Roache, Chamindi Seneviratne, Susan E Bergeson, Nassima Ait-Daoud, Michael A Dawes, Jennie Z M. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 1. 2008-05-02. PMID:17950969. |
more l-carriers than their ss counterparts had vmax for 5-ht uptake below 200 nmol/10(7) platelets-min (p<0.05) and bmax for paroxetine binding below 600 nmol/mg protein (p<0.06). |
2008-05-02 |
2023-08-12 |
human |
| Bankole A Johnson, Martin A Javors, John D Roache, Chamindi Seneviratne, Susan E Bergeson, Nassima Ait-Daoud, Michael A Dawes, Jennie Z M. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 1. 2008-05-02. PMID:17950969. |
current drinking (drinks per day during the past 14 days) correlated positively with km and vmax of platelet 5-ht uptake (p<0.05) and negatively with bmax, but not kd, of paroxetine binding (p<0.05) for l-carriers alone. |
2008-05-02 |
2023-08-12 |
human |
| Bankole A Johnson, Martin A Javors, John D Roache, Chamindi Seneviratne, Susan E Bergeson, Nassima Ait-Daoud, Michael A Dawes, Jennie Z M. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 1. 2008-05-02. PMID:17950969. |
years of lifetime drinking correlated negatively with km and vmax of platelet 5-ht uptake (p<0.05) and b(max), but not kd, of paroxetine binding (p<0.05) for l-carriers alone. |
2008-05-02 |
2023-08-12 |
human |
| Bankole A Johnson, Martin A Javors, John D Roache, Chamindi Seneviratne, Susan E Bergeson, Nassima Ait-Daoud, Michael A Dawes, Jennie Z M. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 1. 2008-05-02. PMID:17950969. |
among l-carriers alone, there were higher levels of platelet 5-ht uptake and lower levels of platelet paroxetine binding with increased drinking, and more lifetime drinking was associated with modestly lower levels of 5-ht uptake and paroxetine binding. |
2008-05-02 |
2023-08-12 |
human |